Pernix Therapeutics Holdings, Inc.
PTX
PTX was delisted on the 4th of March, 2019.
101 hedge funds and large institutions have $128M invested in Pernix Therapeutics Holdings, Inc. in 2015 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 36 increasing their positions, 27 reducing their positions, and 16 closing their positions.
33% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 27
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
3% less funds holding
Funds holding: 104 → 101 (-3)
6% less capital invested
Capital invested by funds: $135M → $128M (-$7.62M)
19% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 16
66% less call options, than puts
Call options by funds: $85K | Put options by funds: $248K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$15.6M |
| 2 |
Millennium Management
New York
|
+$1.59M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
+$1.45M |
| 4 |
ECP
Elk Creek Partners
Denver,
Colorado
|
+$1.18M |
| 5 |
Renaissance Technologies
New York
|
+$1.16M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$15.2M |
| 2 |
ACA
Avoro Capital Advisors
New York
|
-$2.6M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$2.52M |
| 4 |
DCM
DG Capital Management
New York
|
-$2.2M |
| 5 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$2.04M |
PTX Hedge Fund Activity: Q4 2015 in Review
101 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Pernix Therapeutics Holdings, Inc. (PTX) for Q4 2015, worth a combined $128M — down 5.6% from $135M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of PTX and 13 opened new positions — a net loss of 3 holders — while 27 trimmed existing stakes and 36 added.
The largest buyer was Morgan Stanley, adding an estimated $15.6M. The largest seller was Armistice Capital, exiting entirely with an estimated $15.2M sold.
- 101 institutional investors held Pernix Therapeutics Holdings, Inc. (PTX) as of Q4 2015, down from 104 in Q3 2015.
- Funds reported $128M of Pernix Therapeutics Holdings, Inc. stock for Q4 2015, down 5.6% quarter-over-quarter.
- 13 funds opened new Pernix Therapeutics Holdings, Inc. positions in Q4 2015 and 16 closed out, a net change of -3 holders.
- The largest Pernix Therapeutics Holdings, Inc. buyer in Q4 2015 was Morgan Stanley, an estimated $15.6M added.
- The largest Pernix Therapeutics Holdings, Inc. seller in Q4 2015 was Armistice Capital, an estimated $15.2M sold.
Based on aggregated 13F filings for Q4 2015.